title: [Agranulocytosis in a patient treated with metamizole and clopidogrel].
authors.affiliation: Klinische Pharmakologie & Toxikologie, Universitätsspital Basel.
authors.forename: O
authors.initials: O
authors.lastname: Kummer
authors.forename: M
authors.initials: M
authors.lastname: Haschke
authors.forename: D
authors.initials: D
authors.lastname: Tuchscherer
authors.forename: M
authors.initials: M
authors.lastname: Lampert
authors.forename: F
authors.initials: F
authors.lastname: Martius
authors.forename: S
authors.initials: S
authors.lastname: Krähenbühl
mesh_terms: D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D002544:Cerebral Infarction / Q000188:drug therapy*; D000077144:Clopidogrel; D004177:Dipyrone / Q000009:adverse effects* / Q000627:therapeutic use; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D008297:Male; D020370:Osteoarthritis, Knee / Q000188:drug therapy*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010975:Platelet Aggregation Inhibitors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D004177:Dipyrone; D000077144:Clopidogrel; D013988:Ticlopidine; D000069585:Filgrastim